Patent · US Active

Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors

US11865134B2 · kind B2 · utility

0Cited by

21References

3Claims

0Family size

Assignee

REGENERON PHARMACEUTICALS, INC. · US

Inventors

Gaurang Patel · Tarrytown, US
Ying Hu · Scarsdale, US
Kavita Praveen · Tarrytown, US
Giovanni Coppola · Tarrytown, US
Goncalo Abecasis · Tarrytown, US
Aris Baras · Tarrytown, US
Carmelo Romano · Tarrytown, US

Key dates

Filing date	Feb 23, 2022
Grant date	Jan 9, 2024
Priority date	—
Expiry date	Feb 23, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides methods of treating subjects having inflammation with an Angiopoietin-Like 7 (ANGPTL7) inhibitor and a glucocorticoid, methods of decreasing glucocorticoid-induced ophthalmic conditions in subjects, and methods of identifying subjects having an increased risk of developing glucocorticoid-induced ophthalmic conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.